The novel treatment of this peptide represents a exciting breakthrough in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide515204.blogdal.com/42435113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment